Gordon Dunn is CFO at Quoin Pharmaceuticals, Ltd. (QNRX). They have made 2 open-market trades across 1 company since 2024, most recently 2024-12-23.
CIK 0001958139
2 open-market purchases totalling $133K since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| QNRX | 151,077 | $609K |
Shares reported on the most recent Form 4, priced at the 2024-12-27 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.